Evidence map›Paper›PMID 39595619›Full record

ReviewBiomolecules2024

Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities.

Roberta Veglia Tranchese, Sabrina Battista, Laura Cerchia, Monica Fedele

Abstract readReview
In one paragraph

Review in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Ferroptosis in Cancer: Mechanism and Therapeutic Potential.International journal of molecular sciences · 2025
    Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Roberta Veglia TrancheseInstitute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council-CNR, 80131 Naples, Italy.
Sabrina BattistaInstitute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council-CNR, 80131 Naples, Italy.ORCID 0000-0001-5899-9759
Laura CerchiaInstitute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council-CNR, 80131 Naples, Italy.ORCID 0000-0002-7633-7932
Monica FedeleInstitute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council-CNR, 80131 Naples, Italy.ORCID 0000-0002-9171-1312

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has emerged as a critical pathway in cancer biology. This review delves into the epigenetic mechanisms that modulate ferroptosis in cancer cells, focusing on how DNA methylation, histone modifications, and non-coding RNAs influence the expression and function of essential genes involved in this process. By unraveling the complex interplay between these epigenetic mechanisms and ferroptosis, the article sheds light on novel gene targets and functional insights that could pave the way for innovative cancer treatments to enhance therapeutic efficacy and overcome resistance in cancer therapy.

Indexed as

DNA MethylationEpigenesis, GeneticFerroptosisNeoplasmsAnimalsGene Expression Regulation, NeoplasticHumansLipid PeroxidationRNA, UntranslatedRNA, Untranslatedcancer therapyepigenetic regulationferroptosislipid peroxidationtherapeutic targets

Identifiers

PMID39595619
PMCPMC11592303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.